Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma

BACKGROUND: The resulting clinical impact of the combined use of G-CSF with chemotherapy as a chemosensitizing strategy for treatment of acute myeloid leukemia (AML) patients is still controversial. In this study, the effect of ex vivo treatment with G-CSF on AML primary blasts was studied. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomdedeu, Meritxell, Lara-Castillo, María Carmen, Etxabe, Amaia, Cornet-Masana, Josep María, Pratcorona, Marta, Díaz-Beyá, Marina, Calvo, Xavier, Rozman, María, Costa, Dolors, Esteve, Jordi, Risueño, Ruth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687155/
https://www.ncbi.nlm.nih.gov/pubmed/26696777
http://dx.doi.org/10.1186/s12935-015-0272-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687155/
https://www.ncbi.nlm.nih.gov/pubmed/26696777
http://dx.doi.org/10.1186/s12935-015-0272-3

Ejemplares similares